Rtw Investments, LP Exagen Inc. Transaction History

Rtw Investments, LP

$6.51 Billion
Q2 2025

A detailed history of Rtw Investments, LP transactions in Exagen Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 1,696,866 shares of XGN stock, worth $16.2 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

1,696,866

Previous 1,511,866 12.24%

Holding current value

$16.2 Million

Previous $5.43 Million 118.24%

% of portfolio

0.18%

Previous 0.09%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$3.93 - $7.71 $727,050 - $1.43 Million	185,000 Added 12.24%	1,696,866 $11.8 Million
Q2 2024 Aug 14, 2024	BUY	$1.36 - $2.05 $9,879 - $14,891	7,264 Added 0.48%	1,511,866 $2.75 Million
Q4 2023 Feb 14, 2024	BUY	$1.45 - $2.39 $17,646 - $29,086	12,170 Added 0.82%	1,504,602 $2.99 Million
Q2 2023 Aug 14, 2023	BUY	$2.36 - $3.48 $238,945 - $352,343	101,248 Added 7.28%	1,492,432 $4.33 Million
Q1 2023 May 15, 2023	BUY	$2.23 - $2.9 $59,871 - $77,859	26,848 Added 1.97%	1,391,184 $3.38 Million
Q4 2022 Feb 14, 2023	BUY	$2.1 - $3.4 $662,915 - $1.07 Million	315,674 Added 30.1%	1,364,336 $3.27 Million
Q3 2022 Nov 14, 2022	BUY	$2.69 - $8.68 $63,645 - $205,368	23,660 Added 2.31%	1,048,662 $2.84 Million
Q2 2022 Aug 15, 2022	BUY	$4.18 - $7.74 $145,710 - $269,808	34,859 Added 3.52%	1,025,002 $5.88 Million
Q1 2022 May 16, 2022	BUY	$7.12 - $11.06 $1.2 Million - $1.87 Million	168,729 Added 20.54%	990,143 $7.95 Million
Q2 2021 Aug 13, 2021	SELL	$12.4 - $17.92 $9.98 Million - $14.4 Million	-804,951 Reduced 49.49%	821,414 $12.3 Million
Q1 2021 May 14, 2021	BUY	$13.9 - $22.0 $5.23 Million - $8.28 Million	376,234 Added 30.1%	1,626,365 $28.5 Million
Q3 2020 Nov 16, 2020	SELL	$10.56 - $16.69 $52,800 - $83,450	-5,000 Reduced 0.4%	1,250,131 $13.6 Million
Q2 2020 Aug 14, 2020	SELL	$11.0 - $16.7 $5,599 - $8,500	-509 Reduced 0.04%	1,255,131 $15.6 Million
Q1 2020 May 15, 2020	BUY	$12.7 - $25.95 $6.82 Million - $13.9 Million	536,694 Added 74.65%	1,255,640 $20 Million
Q4 2019 Feb 14, 2020	BUY	$12.61 - $28.48 $2.61 Million - $5.9 Million	207,313 Added 40.52%	718,946 $18.3 Million
Q3 2019 Nov 14, 2019	BUY	$14.5 - $17.5 $7.42 Million - $8.95 Million	511,633 New	511,633 $7.93 Million

Others Institutions Holding XGN

# of Institutions

Shares Held

9.08M

Call Options Held

Put Options Held

View Full List

About EXAGEN INC.

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $155M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

More about XGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.

Account

Rtw Investments, LP Exagen Inc. Transaction History